Stratview Research has published a new report on the Anticancer Drug Market, segmented By Type (Targeted Drugs, Cytotoxic Drugs, Hormonal Drugs), Application (Immunotherapy, Targeted Therapy, Chemotherapy, Hormonal Therapy, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Region.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global artificial intelligence as a service market.
Market Highlights
The Anticancer Drug Market is projected to grow from USD 141.6 billion in 2020 to USD 215.5 billion by 2026 at a CAGR of around 7.4% during the forecast period.
To know more about the covid impact on the market, click here: https://www.stratviewresearch.com/Request-Sample/2417/Anticancer-Drug-Market.html#form
Covid Impact
Covid-19 has impacted the market dynamics, competition, and global supply chain of every possible market one can think of. The revenues for many, have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operations and strategy will sustain and beat the competition.
Segmentation –
This report studies the Anticancer Drug Market and has segmented the market in a few ways, keeping in mind the concentration of all the stakeholders across the value chain. Following are the ways in which the market has been segmented in the report:
By application, the anticancer drug market has been bifurcated into immunotherapy, targeted therapy, chemotherapy, hormonal therapy, and others. The chemotherapy segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period.
By region, the North American market accounted for the largest market share in 2020 and is projected to grow at a robust CAGR during the review period. This can be attributed to rising healthcare expenditure, the presence of a large patient population, and early adoption of advanced drugs coupled with the presence of key market players such as Celgene Corporation (US) and Pfizer Inc. (US). The market growth in Asia-Pacific is expected to be driven by the rising number of cancer patients coupled with increasing investment in R&D activities to develop advanced cancer treatment solutions.
Following are the key players in the Anticancer Drug Market:
· F. Hoffmann-La Roche AG (Switzerland)
· Celgene Corporation (US)
· Pfizer Inc. (US)
· Bristol Myers Squibb (US)
· Novartis International AG (Switzerland)
· AstraZeneca plc (UK)
· Teva Pharmaceutical Industries Ltd (Israel)
· Bayer AG (Germany)
· GlaxoSmithKline plc (UK)
About Stratview Research-
Stratview Research is a global market intelligence firm having a strong team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. Our services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.
Connect with our team here–
https://www.stratviewresearch.com/contact
Or
Call us @: +1-313-307-4176
Write a comment